AZ HB2322

Adds manufacturing, selling or distributing misbranded drugs in violation of section 13-3406, subsection A, paragraph 9 to the definition of "racketeering" for purposes of criminal syndicate prosecution.

Creates new offenses in section 13-3406 making it unlawful to possess or use a misbranded drug (class 2 misdemeanor) and to manufacture, sell or distribute a misbranded drug (class 4 felony).

Defines "misbranded drug" in section 13-3406 by reference to section 32-1967, which describes what constitutes misbranding of drugs and devices.

Adds section 32-1967(A)(17) prohibiting foreign dangerous drugs that are not approved by FDA or obtained outside the licensed supply chain, with exceptions for state-authorized uses, lawful FDA imports, and specific purposes including clinical research and pandemic preparedness.

Updates section 32-1967 to clarify misbranding exceptions for pharmaceutical compounding and pharmacy filling errors, and defines "dangerous drug" for purposes of the misbranding statute.